Genexpath develops, produces and markets innovative products resulting from academic research.
Our mission
Characterize pathologies to better understand them
At Genexpath, we are committed to enabling you to deepen your understanding of pathologies by characterizing them with precision. Through a combination of scientific and bioinformatics expertise and innovative molecular biology approaches, we enable you to explore the underlying mechanisms of diseases to provide crucial information for more accurate diagnosis and more effective management.
Our vision
Providing access to molecular biology and bioinformatics tools to as many people as possible
We believe that scientific advances should be accessible to everyone. This is why we strive to make molecular biology and bioinformatics tools accessible to researchers, clinicians and health institutions, in order to democratize innovation and enable better treatment of pathologies. We are committed to offering turnkey solutions from the bench to bioinformatics analysis of data, in order to improve diagnostics and accelerate medical discoveries.
Genexpath's Team
Genexpath team is multidisciplinary. It brings together diverse and complementary expertise, all dedicated to the development of innovative products
We ensure the production and quality control of our products in our premises in Rouen, Normandy. We thus guarantee complete control of test manufacturing. IT applications are also developed in-house, in order to best meet the needs and expectations of our users.
The team offers optimal support to our users in the use of our solutions.
The Henri Becquerel Center team
Henri Becquerel Cancer center (Inserm U1245) team, directed by Professor Fabrice Jardin has been working for several years in collaboration with other establishments to develop innovative solutions to classify lymphomas and detect fusion transcripts in various pathologies and in particular sarcomas.
This team intervenes on a regular basis and allows for the continuous improvement of products. It also contributes to the development of the company's future products.
A word from the CEO
Genexpath is the result of an encounter.
A meeting with the team of the INSERM unit in Rouen. I was very quickly won over by the personality of the members of this team and by their research and the vision they had
We collectively very quickly thought that this work could be made available to as many people as possible through the creation of a company. This is how Genexpath was born.
I am proud to have been welcomed by these researchers, proud to have contributed to the dissemination of this work and proud of all the work accomplished by the Genexpath team.
Certifications and quality policy
Genexpath is certified ISO 13 485 : 2016.
This certification attests to the design, production and distribution activities of our diagnostic medical devices in Vitro test et nos produits destinés à la recherche.
Genexpath is committed to producing quality services, reflecting our commitment to the highest standards. We guarantee maximum reliability and efficiency for users of our products.
This quality management system has the following strategic objectives:
- Develop products in line with developments in the market for the diagnosis of targeted pathologies and research
- Continuously improve the quality of our products and services with a view to always better meeting the expectations of our customers and thus retaining their loyalty
- Ensure compliance of our products and services with regulatory requirements for diagnostic medical devices in Vitro test, as well as with the ethical requirements of a player in the health sector
- Developing and involving company staff
- Ensure continuous improvement of the QMS and maintenance of ISO 13485 certification
